Table 3 Gamma passing rate of CCR-VMAT plans for the C-shaped phantom and prostate cancers. The prostate cancer data are means ±2 standard deviations
Trajectory | C-shaped phantom | Prostate cancers (n = 5) | ||||
|---|---|---|---|---|---|---|
3%/3 mm [%] | 3%/1 mm [%] | 5%/1 mm [%] | 3%/3 mm [%] | 3%/1 mm [%] | 5%/1 mm [%] | |
1 | 98.0 | 91.5 | 97.5 | 98.3 ± 1.7 | 86.5 ± 2.8 | 95.9 ± 1.4 |
2 | 99.1 | 92.1 | 98.6 | 98.2 ± 0.5 | 84.9 ± 0.5 | 95.9 ± 2.2 |
3 | 99.2 | 92.0 | 98.5 | 98.4 ± 1.9 | 85.8 ± 1.8 | 95.8 ± 0.9 |
4 | 99.6 | 96.7 | 99.6 | 98.5 ± 0.8 | 88.2 ± 4.8 | 96.5 ± 2.8 |
5 | 99.0 | 92.5 | 98.3 | 97.8 ± 1.0 | 86.0 ± 3.8 | 96.0 ± 2.5 |
6 | 98.9 | 90.2 | 98.1 | 97.5 ± 1.6 | 85.8 ± 3.6 | 95.9 ± 2.4 |
7 | 99.5 | 95.8 | 99.2 | 97.2 ± 2.3 | 87.1 ± 5.7 | 95.8 ± 1.8 |